{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:58:59Z","timestamp":1761893939016},"reference-count":45,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1080\/00365540410019381","type":"journal-article","created":{"date-parts":[[2004,5,2]],"date-time":"2004-05-02T03:20:43Z","timestamp":1083468043000},"page":"244-253","source":"Crossref","is-referenced-by-count":23,"title":["Impact of switching antiretroviral therapy on lipodystrophy and other metabolic complications: a review"],"prefix":"10.1080","volume":"36","author":[{"given":"Birgitte R","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen B","family":"Haugaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Ole","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ove","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042560-199903010-00003","volume":"20","author":"Kotier DP","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"CIT0002","first-page":"F51","volume":"12","author":"Carr A","year":"1998","journal-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1310\/BRE5-448N-WUPU-JWVL","volume":"2","author":"Boufassa F","year":"2001","journal-title":"HIV Clin Trials"},{"key":"CIT0004","first-page":"592","volume":"357","author":"Martinez E","year":"2001","journal-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet"},{"key":"CIT0005","first-page":"37","volume":"14","author":"Saint-Marc T","year":"2000","journal-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"Carr A","year":"2003","journal-title":"Lancet"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","volume":"23","author":"Mulligan K","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00126334-200308010-00018","volume":"33","author":"Lafeuillade A","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","volume":"15","author":"van der Valk M","year":"2001","journal-title":"AIDS"},{"issue":"1","key":"CIT0010","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/00126334-200309011-00011","volume":"34","author":"Carr. A","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CIT0011","first-page":"1179","volume":"17","author":"Friis-Moller N","year":"2003","journal-title":"Cardiovascular disease risk factors in HIV patients: association with antiretroviral therapy. Results from the DAD study, AIDS"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00002030-200308150-00017","volume":"17","author":"Katlama C","year":"2003","journal-title":"AIDS"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00126334-200005010-00014","volume":"24","author":"Duncombe C","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CIT0016","first-page":"2191","volume":"15","author":"Wensing AM","year":"2001","journal-title":"Replacing ritonavir by nelfinavir or nelfinavir\/saquinavir as part of highly active antiretroviral therapy leads to an improvement of triglyceride levels. AIDS"},{"key":"CIT0018","first-page":"1343","volume":"52","author":"Andersen O","year":"2003","journal-title":"Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function. Metabolism"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1086\/317541"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","volume":"16","author":"Noor MA","year":"2002","journal-title":"AIDS"},{"key":"CIT0021","first-page":"413","volume":"6","author":"Walli RK","year":"2001","journal-title":"Eur J Med Res"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1086\/317426"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00126334-200112010-00016","volume":"28","author":"Moyle G","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CIT0025","first-page":"69","volume":"35","author":"Estrada V","year":"2002","journal-title":"Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy. Clin Infect Dis"},{"key":"CIT0029","first-page":"805","volume":"13","author":"Martinez E","year":"1999","journal-title":"Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine. AIDS"},{"key":"CIT0030","author":"Tebas P","year":"2000","journal-title":"Evolution of multiple metabolic parameters after switch of protease inhibitors to nevirapine (abstract ThPpB1485). Programs and abstracts of the 13th International Conference on AIDS (Durban"},{"key":"CIT0031","first-page":"22","volume":"33","author":"Moyle GJ","year":"2003","journal-title":"A 48-week, randomized, open-label comparison of 3 abacavir-based substitution approaches in the management of dyslipidaemia and peripheral lipoatrophy. J Acquir Immune Defic Syndr"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","volume":"288","author":"Carr A","year":"2002","journal-title":"JAMA"},{"key":"CIT0035","first-page":"2489","volume":"16","author":"Smith DE","year":"2002","journal-title":"Cooper DA. Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromizes antiviral control: the PIILR extension study. AIDS"},{"key":"CIT0036","first-page":"1045","volume":"74","author":"Grunfeld C","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-978655","volume":"32","author":"Petit JM","year":"2000","journal-title":"Horm Metab Res"},{"key":"CIT0038","first-page":"859","volume":"33","author":"Echevarria KL","year":"1999","journal-title":"Hyperlipidaemia associated with protease inhibitor therapy. Ann Pharmacother"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199713000-00014"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/00002030-200112070-00008","volume":"15","author":"van der V","year":"2001","journal-title":"AIDS"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/340312","volume":"185","author":"Opravil M","year":"2002","journal-title":"J Infect Dis"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1310\/X9BK-C45Q-HQKJ-WJ4N","volume":"2","author":"Knechten H","year":"2001","journal-title":"HIV Clin Trials"},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00126334-200107010-00003","volume":"27","author":"Ruiz L","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CIT0047","first-page":"807","volume":"14","author":"Barreiro P","year":"2000","journal-title":"Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under longterm successful triple combination therapy. AIDS"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200207050-00010"},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1086\/324629","volume":"34","author":"Negredo E","year":"2002","journal-title":"Clin Infect Dis"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00126334-200305010-00005","volume":"33","author":"John M","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109280-00010"},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1310\/EJRF-JGGH-GRCD-MED8","volume":"4","author":"Lafeuillade A","year":"2003","journal-title":"HIV Clin Trials"},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1086\/317424","volume":"31","author":"Raffi F","year":"2000","journal-title":"Clin Infect Dis"},{"key":"CIT0059","first-page":"921","volume":"17","author":"Garcia-Benayas T","year":"2003","journal-title":"Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy. AIDS"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00002030-200108170-00009","volume":"15","author":"Clumeck N","year":"2001","journal-title":"AIDS"},{"key":"CIT0063","first-page":"389","volume":"26","author":"Doser N","year":"2001","journal-title":"Persistent dyslipidaemia in HIV-infected individuals switched from a protease inhibitor-containing to an efavirenz-containing regimen. J Acquir Immune Defic Syndr"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021589"}],"container-title":["Scandinavian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00365540410019381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T06:46:54Z","timestamp":1497595614000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00365540410019381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2004,4]]}},"alternative-id":["10.1080\/00365540410019381"],"URL":"https:\/\/doi.org\/10.1080\/00365540410019381","relation":{},"ISSN":["0036-5548","1651-1980"],"issn-type":[{"value":"0036-5548","type":"print"},{"value":"1651-1980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}